These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24089139)

  • 21. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
    Geng Q; Deng H; Fu J; Cui F
    Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
    Lu D; Han C; Wu T
    Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo.
    Foster DJ; Barros S; Duncan R; Shaikh S; Cantley W; Dell A; Bulgakova E; O'Shea J; Taneja N; Kuchimanchi S; Sherrill CB; Akinc A; Hinkle G; Seila White AC; Pang B; Charisse K; Meyers R; Manoharan M; Elbashir SM
    RNA; 2012 Mar; 18(3):557-68. PubMed ID: 22294662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
    J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference: mechanisms, technical challenges, and therapeutic opportunities.
    Sioud M
    Methods Mol Biol; 2015; 1218():1-15. PubMed ID: 25319642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer.
    Machitani M; Sakurai F; Wakabayashi K; Tachibana M; Fujiwara T; Mizuguchi H
    Mol Cancer Ther; 2017 Jan; 16(1):251-259. PubMed ID: 27760834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of β-catenin gene silencing by shRNA on biologic characteristics of human esophageal carcinoma cells].
    Wang JS; Ji AF; Wen JF; Ren HZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):835-41. PubMed ID: 21215100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
    Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
    Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells.
    Wang X; Yuan C; Huang B; Fan J; Feng Y; Li AJ; Zhang B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Wu D; Chen X; Liu B; Wagstaff W; He F; Wu X; Luo H; Zhang J; Zhang M; Haydon RC; Luu HH; Lee MJ; Moriatis Wolf J; Huang A; He TC; Zeng Z
    ACS Synth Biol; 2019 Sep; 8(9):2092-2105. PubMed ID: 31465214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.
    He H; Huynh N; Liu KH; Malcontenti-Wilson C; Zhu J; Christophi C; Shulkes A; Baldwin GS
    Cancer Lett; 2012 Apr; 317(1):65-71. PubMed ID: 22100495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling.
    Wang W; Xu L; Liu P; Jairam K; Yin Y; Chen K; Sprengers D; Peppelenbosch MP; Pan Q; Smits R
    Neoplasia; 2016 Dec; 18(12):711-723. PubMed ID: 27851986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth inhibition effect of β-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cells.
    Xu WL; Wang Q; Du M; Zhao YH; Sun XR; Sun WG; Chen BQ
    Cancer Biother Radiopharm; 2010 Oct; 25(5):529-37. PubMed ID: 20950152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.
    Kubo T; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2016 Jun; 87(6):811-23. PubMed ID: 26800111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.